These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 1287465)

  • 1. [Induction of LAK-like cells in the regional lymph nodes and spleen by intralymph-nodal injection of OK-432: preliminary report].
    Sakakura C; Takahashi T; Sawai K; Hagiwara A; Yamane T; Okano S; Tsujimoto H
    Nihon Geka Gakkai Zasshi; 1992 Dec; 93(12):1506. PubMed ID: 1287465
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhancement of LAK-like activity and cytokine induction in regional lymph nodes and spleen cells of mice after intralymphnodal injection of OK-432, a killed streptococcal preparation.
    Sakakura C; Takahashi T; Hagiwara A; Yamane T; Sawai S; Okano S; Ozaki K; Sasaki S; Tsujimoto H
    Anticancer Drugs; 1993 Jun; 4(3):381-8. PubMed ID: 8358067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective in vivo induction of lymphokine-activated killer (LAK) cells by pretreatment with a streptococcal preparation, OK-432.
    Shimoda K; Saito T; Kobayashi M; Nomoto K
    Biotherapy; 1992; 5(1):63-9. PubMed ID: 1389903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction by OK-432 of lymphokine activated killer precursor cells in hepatocellular carcinoma.
    Aramaki M; Kim YI; Shimoda K; Nakashima K; Okada K; Kobayashi M
    Hepatogastroenterology; 1994 Aug; 41(4):363-6. PubMed ID: 7959572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation of cytotoxicity of lymphokine activated killer cells on ovarian tumor cells by various biological response modifiers.
    Nio Y; Zighelboim J; Berek JS; Bonavida B
    Anticancer Res; 1990; 10(2A):441-6. PubMed ID: 2346317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OK-432 develops CTL and LAK activity in mononuclear cells from regional lymph nodes of lung cancer patients.
    Takahashi K; Harauchi D; Kimura S; Saito S; Monden Y
    Int J Immunopharmacol; 1998 Aug; 20(8):375-88. PubMed ID: 9778099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A basic study of combination cancer immunotherapy with OK-432 and rIL-2--induction of lymphokine-activated killer (LAK) precursor cells in murine spleen by intravenous administration of OK-432].
    Shimoda K; Saito T; Kobayashi M
    Nihon Gan Chiryo Gakkai Shi; 1988 Jul; 23(7):1566-73. PubMed ID: 3263451
    [No Abstract]   [Full Text] [Related]  

  • 8. [The characteristic of lymphokine-activated killer cells induced from tumor draining lymph-node cell].
    Meng YG; Fu CY; Wang YZ
    Zhonghua Fu Chan Ke Za Zhi; 1994 Sep; 29(9):535-7, 574. PubMed ID: 7835130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation by OK-432 of generation of culture-induced killer cells.
    Ujiie T
    Jpn J Exp Med; 1987 Jun; 57(3):153-61. PubMed ID: 3682231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Induction of anti-cancer cells and systemic immune response in hepatocellular carcinoma by OK-432].
    Aramaki M; Nakashima K; Sasaki A; Shimoda K; Yoshida T; Kim YI; Kitano S; Kobayashi M
    Gan To Kagaku Ryoho; 1994 Sep; 21(13):2115-7. PubMed ID: 7944416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity of ovarian tumor cells to effector cells generated by various biological response modifiers.
    Nio Y; Zighelboim J; Berek JS; Bonavida B
    Nat Immun Cell Growth Regul; 1990; 9(4):283-96. PubMed ID: 2215516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of murine lymphokine-activated killer cells by recombinant IL-7.
    Lynch DH; Miller RE
    J Immunol; 1990 Sep; 145(6):1983-90. PubMed ID: 1975262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Enhancement of cytotoxicity in the regional lymph node cells by local injection of carbon particles adsorbing aclacinomycin a: preliminary report].
    Sakakura C; Takahashi T; Sawai K; Hagiwara A; Yamane T; Ito M; Shobayashi S
    Nihon Geka Gakkai Zasshi; 1992 Jun; 93(6):667. PubMed ID: 1630446
    [No Abstract]   [Full Text] [Related]  

  • 14. In vivo interleukin 2-induced activation of lymphokine-activated killer cells and tumor cytotoxic T-cells in cervical lymph nodes of patients with head and neck tumors.
    Rivoltini L; Gambacorti-Passerini C; Squadrelli-Saraceno M; Grosso MI; Cantù G; Molinari R; Orazi A; Parmiani G
    Cancer Res; 1990 Sep; 50(17):5551-7. PubMed ID: 2386961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Induction of LAK cells in peritoneal cavity of mice after ip injection of OK-432 and antitumor effect of these LAK cells].
    Ishida N; Saito M; Nanjo M
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2681-90. PubMed ID: 6508321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in homing receptor expression on murine lymphokine-activated killer cells during IL-2 exposure.
    Steen PD; McGregor JR; Lehman CM; Samlowski WE
    J Immunol; 1989 Dec; 143(12):4324-30. PubMed ID: 2687380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of lymphokine-activated killer cells from peripheral blood and lymph nodes of non-Hodgkin's lymphoma patients.
    Nadkarni JJ; Jhaver KG; De AK; Soman CS; Nadkarni KS
    Neoplasma; 1993; 40(1):15-20. PubMed ID: 8350943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of endoscopic local injection of OK-432 on regional lymph nodes in gastric cancer patients].
    Ogawara T; Sakai K; Sekikawa T; Kouno K; Matsumoto Y
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1601-4. PubMed ID: 1530316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The precursor cells of mouse lymphokine-activated killer (LAK) cells.
    Nishimura T; Yagi H; Uchiyama Y; Hashimoto Y
    Thymus; 1987; 9(3):131-9. PubMed ID: 3495912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased lymphokine activated killer (LAK) activity in the regional lymph nodes of mice following immunization with contact sensitizing agents.
    Gao LQ; Asherson GL; Malkovsky M
    Clin Exp Immunol; 1987 Oct; 70(1):217-21. PubMed ID: 3500814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.